Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
BD

BOBBI DILLON

Registered · LDAActive

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
WASHINGTON, DC · current

The past 12 months

Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
Executive Office of the President (EOP)HOUSE OF REPRESENTATIVESSENATE

Specific issues

-H.R.4273: Over-the-Counter Monograph Drug User Fee Amendments (Entire Bill)
Health Issues · 2025 Q3
-Issues related to IEEPA Reciprocal Tariffs -Issues related to Softwood Lumber 232 Trade Investigation -Issues related to America First Trade Policy -Issues related to tariffs (232 Pharmaceuticals)
Trade (domestic/foreign) · 2025 Q3
-Issues related to IEEPA Tariffs -Issues related to the Pharmaceuticals Section 232 Trade Investigation -Issues related to Lumber Section 232 Trade Investigation
Trade (domestic/foreign) · 2025 Q2
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 3749(IH) Health and Endocrine Research on Personal Care Products for Women Act* -H.R.4273 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes
Health Issues · 2025 Q2

Clients

$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings1
2025 Q3
THE PROCTER AND GAMBLE COMPANY
Q3lda.gov →
Older filings1
2025 Q2
THE PROCTER AND GAMBLE COMPANY
Q2lda.gov →